Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...

Milan's pursuit of youth talent is heating up, with the recent news spotlighting Verona's U21 international defender, Coppola. As soccer clubs increasingly invest in young, promising players, ...

We came across a bullish thesis on Verona Pharma plc (VRNA) on Value Investing Subreddit Page by loud_keyb. In this article, ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Verona Pharma (VRNA – Research Report). The company’s ...

When Danine Alati and Juan Parra made an offer on their first home in Verona, N.J., in 2021, they were among 18 buyers who ...

In the competitive landscape of Serie A, the transfer market is abuzz with news as AC Milan and Juventus vie for the signature of Verona defender Marash Kumbulla. Both clubs have been monitoring his ...

Meeting to be held in Boston on March 10 at 6 pm hosted by Truist. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Driven by a decade of success, Pasqua Wines embraces the future, strengthening its commitment to quality, innovation, and its ...

Juventus are said to have ‘booked’ a move for Hellas Verona’s young centre back Diego Coppola. The 2003 born defender is said ...

Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective increased by HC Wainwright from $60.00 to $75.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on ...